ARTA
ACOR

A.R.T. Advisors’s Acorda Therapeutics ACOR Stock Holding History

A.R.T. Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-230
Closed -$20K – 285
2020
Q2 		$20K Buy
+230
New +$24.3K 0.03% 259
2019
Q1 		– Sell
-238
Closed -$445K – 1705
2018
Q4 		$445K Buy
238
+90
+61% +$196K 0.03% 776
2018
Q3 		$349K Buy
+148
New +$458K 0.02% 987
2018
Q1 		– Sell
-398
Closed -$1.02M – 1825
2017
Q4 		$1.02M Buy
+398
New +$1.13M 0.05% 610
2017
Q1 		– Sell
-373
Closed -$842K – 1789
2016
Q4 		$842K Buy
+373
New +$887K 0.05% 535
2016
Q3 		– Sell
-641
Closed -$1.96M – 1266
2016
Q2 		$1.96M Buy
+641
New +$2.08M 0.1% 321
2016
Q1 		– Sell
-298
Closed -$1.53M – 1727
2015
Q4 		$1.53M Sell
298
-360
-55% -$1.57M 0.07% 385
2015
Q3 		$2.09M Sell
658
-898
-58% -$3.48M 0.08% 361
2015
Q2 		$6.22M Buy
1,556
+637
+69% +$2.46M 0.21% 108
2015
Q1 		$3.67M Buy
+919
New +$4.21M 0.13% 218
2014
Q4 		– Sell
-449
Closed -$1.82M – 1723
2014
Q3 		$1.82M Buy
449
+282
+169% +$1.06M 0.08% 322
2014
Q2 		$675K Buy
+167
New +$681K 0.04% 642
2014
Q1 		– Sell
-486
Closed -$1.7M – 1612
2013
Q4 		$1.7M Buy
486
+168
+53% +$655K 0.09% 328
2013
Q3 		$1.3M Sell
318
-62
-16% -$267K 0.07% 404
2013
Q2 		$1.5M Buy
+380
New +$1.56M 0.05% 475

Other funds holding ACOR

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

A.R.T. Advisors's ACOR Position: Q3 2020 in Review

A.R.T. Advisors sold out of Acorda Therapeutics (ACOR) in Q3 2020, closing a stake of 230 shares — an estimated $20K sold.

A.R.T. Advisors first reported a position in ACOR in Q2 2013 and held it in 15 quarters. The position peaked at $6.22M in Q2 2015. 60 funds tracked by Wall St. Rank hold ACOR as of Q3 2020.

  • A.R.T. Advisors reported no remaining Acorda Therapeutics position as of Q3 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 230 Acorda Therapeutics shares in Q3 2020, an estimated $20K.
  • A.R.T. Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 15 quarters.
  • A.R.T. Advisors's Acorda Therapeutics position peaked at $6.22M in Q2 2015.
  • 60 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.